Home Home Home Inbox Home Search

Event

Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Smoking Status: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies [Board No. P460]

Location: Board no. P460
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Donald P. Tashkin

M.D.
David Geffen School of Medicine at UCLA;UCLA;UCLA David Geffen School of Medicine;UCLA Sch of Medicine

Thomas Goodin

PhD
Sunovion Pharmaceuticals Inc.

Ayca Ozol-Godfrey

PhD
Sunovion Pharmaceuticals Inc.

Shahin Sanjar

PhD/ScD Doctoral Equivalent
Sunovion Pharmaceuticals Inc.

Sanjay Sharma

Bachelors Degree
Sunovion Pharmaceuticals Inc.

Barry Price

RRT, MBA
Sunovion Pharmaceuticals Inc.

Alyssa Bowling

Other Healthcare Related Doctorate (PharmD)
Sunovion Pharmaceuticals Inc.

View Abstract

Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Smoking Status: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies

Parent Sessions

  • A75 - COPD: TARGETS, MODELS, AND CLINICAL STUDIES...
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search